Cargando…

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy

AIMS: Peripartum cardiomyopathy (PPCM) is a rare heart disease, occurring in previously heart‐healthy women during the last month of pregnancy or the first months after delivery due to left ventricular (LV) systolic dysfunction. A common pathomechanistic pathway of PPCM includes increased oxidative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfeffer, Tobias J., Mueller, Julia H., Haebel, Lea, Erschow, Sergej, Yalman, Kuebra C., Talbot, Steven R., Koenig, Tobias, Berliner, Dominik, Zwadlo, Carolin, Scherr, Michaela, Hilfiker‐Kleiner, Denise, Bauersachs, Johann, Ricke‐Hoch, Melanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871652/ https://www.ncbi.nlm.nih.gov/pubmed/36300679 http://dx.doi.org/10.1002/ehf2.14210

Ejemplares similares

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2021)

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
por: Nonhoff, Justus, et al.
Publicado: (2017)

High prevalence of reduced fertility and use of assisted reproductive technology in a German cohort of patients with peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

Increased Cancer Prevalence in Peripartum Cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2019)

Assessment of major mental disorders in a German peripartum cardiomyopathy cohort
por: Pfeffer, Tobias J., et al.
Publicado: (2020)

Peripartum cardiomyopathy
por: Koenig, T., et al.
Publicado: (2018)

Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers
por: Azibani, Feriel, et al.
Publicado: (2020)

Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages
por: Heimerl, Maren, et al.
Publicado: (2020)

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018)

Peripartum cardiomyopathy: current management and future perspectives
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2015)

Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
por: Stapel, Britta, et al.
Publicado: (2017)

Characterization of peripartum cardiomyopathy by cardiovascular magnetic resonance imaging
por: Haghikia, Arash, et al.
Publicado: (2015)

Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart
por: Kirchhoff, Hanna, et al.
Publicado: (2022)

Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study
por: Haghikia, Arash, et al.
Publicado: (2015)

Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline
por: Shibuya, Yuki, et al.
Publicado: (2022)

Breastfeeding in Patients With Heart Failure: Lack of Evidence and Consensus
por: Koenig, Tobias, et al.
Publicado: (2019)

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015)

Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
por: Scherr, Michaela, et al.
Publicado: (2018)

Increased prostaglandin-D(2) in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation
por: Stelling, Elisabeth, et al.
Publicado: (2020)

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2017)

Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis
por: Duncker, David, et al.
Publicado: (2017)

Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism
por: Hoes, Martijn F., et al.
Publicado: (2020)

Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects
por: Pietzsch, Stefan, et al.
Publicado: (2021)

Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
por: Haghikia, A., et al.
Publicado: (2013)

Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
por: Meyer, Gerd Peter, et al.
Publicado: (2010)

Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high‐dose bromocriptine therapy
por: Horn, Patrick, et al.
Publicado: (2017)

Data on left ventricular expression of STAT3 and AKT in transgenic mouse models with B16F10 melanoma
por: Pietzsch, Stefan, et al.
Publicado: (2019)

Common genetic predisposition for heart failure and cancer
por: Pfeffer, Tobias J., et al.
Publicado: (2020)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020)

Acute echocardiographic and electrocardiographic effects of triggered left ventricular pacing
por: Pfeffer, Tobias Jonathan, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
por: Wang, Dong, et al.
Publicado: (2023)

Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis
por: Kattih, Badder, et al.
Publicado: (2019)

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
por: Dutzmann, Jochen, et al.
Publicado: (2015)

Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
por: Hoch, Melanie, et al.
Publicado: (2011)

Peripartum Cardiomyopathy
por: Okeke, TC, et al.
Publicado: (2013)

Peripartum cardiomyopathy
por: Bews, Hilary, et al.
Publicado: (2021)

Peripartum Cardiomyopathy
por: Morris, Victoria L, et al.
Publicado: (2023)

Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy
por: Sonnenschein, Kristina, et al.
Publicado: (2019)

Current Drug Therapy in Chronic Heart Failure: the New Guidelines of the European Society of Cardiology (ESC)
por: Berliner, Dominik, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0d63i21ep4n1l1s6qm7mqjrei2